NeoCytex BioPharma's Incubator/Accelerator Round

NeoCytex BioPharma raised a round of funding on , .

NeoCytex BioPharmaceuticals develops therapeutics to promote the repair and rejuvenation of damaged tissues. The lead drug candidate NBI-18 is being developed for speeding up recovery from neurodegene…

Articles about NeoCytex BioPharma's Incubator/Accelerator Round: